Document:

EX-10.63

 Exhibit 10.63 

CONFORMED COPY 
 WebMD Health
Corp. 
 111 Eighth Avenue 
 New
York, NY 10011 
 March 5, 2013 
 Doug Wamsley 

c/o WebMD Health Corp. 
 111 Eighth Avenue 

New York, NY 10011 
 Dear Doug, 

This letter will confirm the terms of the amendment to your employment letter (the “Offer Letter”) with WebMD Health Corp. (the “Company”
or “WebMD”) dated as of July 14, 2005 and as amended as of December 14, 2008 and July 23, 2011. The Offer Letter is amended, effective as of the date hereof, as follows: 

1. Your base salary referred to in the first sentence of Section 2(a) shall be changed to $350,000, effective
March 11, 2013. 
 2. Section 2(b) of the Offer Letter is hereby amended to read in its entirety as follows: 

“(b)(i) You will be entitled to receive an annual bonus of $200,000 for the year ended December 31, 2012 (the “2012
Bonus”), payable as follows: (A) $40,000 of the 2012 Bonus will be paid at the time that bonuses are paid to other executives of the Company for the year ended December 31, 2012, so long as you are employed on such date, and
(B) subject to the terms of the Company’s Supplemental Bonus Plan and Section 9 below, an amount equal to $160,000 will be contributed into the Supplemental Bonus Trust. 

(b)(ii) You will be eligible for an annual bonus for the year ended December 31, 2013, the target of which will be 43% of
your base salary, with the opportunity to earn a total bonus of up to 86% of your bonus target (i.e., $300,000) (the “2013 Bonus”), as follows: 

(A) Up to $150,000 will be payable based upon achievement of the 2013 revenue and earnings targets approved by the Compensation
Committee, with input from the Board of Directors. Sixty percent (60%) of the $150,000 (i.e., $90,000) will be allocated to the achievement of the approved revenue target and forty percent (40%) of the $150,000 (i.e., $60,000) will be
allocated to achievement of the approved earnings target. The Compensation Committee will also establish the amount of the payment associated with the levels of achievement within the approved revenue and earnings ranges. 

(B) Up to $150,000 will be payable based upon an assessment of your individual performance goals provided to you (the
“Performance Goals”). Any 2013 Bonus will be paid at the time that bonuses are paid to other executives of the Company for the year ended December 31, 2013 (to the extent applicable, such amount to be paid from the Supplemental Bonus
Trust), so long as you are employed on the payment date, except as set forth in Section 9. 
 (b)(iii) For fiscal years subsequent to
the year ending December 31, 2013, you will be eligible for an annual bonus, the target of which will be 43% of your base salary, but which amount will be determined in the sole discretion of the Compensation Committee or its designee. 

 (b)(iv) The determination as to whether the financial goals in Section 2(b)(ii)(A) and the
Performance Goals in Section 2(b)(ii)(B) have been attained shall be made by the CEO and Compensation Committee in their sole discretion. Adjustments shall be made by the Compensation Committee to the goals in its discretion to reflect the
effect of acquisitions/divestitures and any other circumstances. The financial goals in Section 2(b)(ii)(A) will be established within sixty (60) days of the date of this Agreement for the 2013 year.” 

3. A new Section 5(c) and a new Section 5(d) are added to read in their entirety as follows: 

“(c) Subject to the approval of the Compensation Committee, you will be granted on March 1, 2013 (the “2013 Restricted Stock
Grant Date”), 10,000 shares of restricted stock of WebMD (the “2013 First Restricted Stock Grant”) under the terms of the Equity Plan. 100% of the 2013 Restricted Stock Grant shall vest and the restrictions thereon lapse on the third
anniversary of the 2013 First Restricted Stock Grant Date, subject to your continued employment on such date; provided that subject to your continued employment on March 15, 2014 if the CEO and Compensation Committee, in their sole discretion,
determine that you have achieved the Performance Goals referred to above, the 2013 Restricted Stock Grant shall vest and the restrictions thereon shall lapse on such date. In addition, in the event of a termination of your employment by the Company
(or its successor) without Cause or by you for Good Reason, in each case, following a Change of Control of WebMD (as defined below), the shares subject to the 2013 Restricted Stock Grant shall vest in full and the restrictions thereon shall lapse.
The 2013 Restricted Stock Grant will be evidenced by the Company’s form of restricted stock agreement. 
 Section 6(a) of the
Offer Letter is hereby amended to read in its entirety as follows: 
 “6(a). Termination of Employment without Cause.  

(a) In the event of the termination of your employment by the Company without Cause or by you for Good Reason (as such terms are defined on
Annex A attached hereto), subject to Section 6(b) below and your continued compliance with the Trade Secret & Proprietary Information Agreement, (i) you will continue to receive, as severance, your base salary in effect on the
date of such termination for a period of twelve (12) months (the “Severance Period”); (ii) if your termination date is effective on or after July 1 of any year subsequent to December 31, 2013 but before the payment of
bonuses for any such year, you shall be entitled to the bonus that you would have received for such year at the time that bonuses are paid to other executive officers of the Company, but in no event later than March 15 of the year following the
year to which the bonus relates, (iii) if the Compensation Committee, in their sole discretion, determine that your Performance Goals referred to above have been achieved, the 2013 Restricted Stock Grant shall vest and the restrictions thereon
shall lapse, and (iv) if you timely elect to continue your health insurance pursuant to COBRA, the Company shall reimburse you for the cost of your COBRA for a period of twelve (12) months from the date of termination, or, if earlier,
until such time as you are no longer eligible for COBRA or are otherwise eligible for comparable coverage with a subsequent employer, which reimbursement shall be made within thirty (30) days after you provide evidence of your payment of such
premiums, which evidence shall be provided no later than thirty (30) days after payment. You shall promptly notify the Company if you become eligible for comparable coverage with another employer. In the event of (i) a termination of your
employment by the Company (or its successor) without Cause or by you for Good Reason, in each case, following a Change of Control of WebMD (as defined below), subject to Section 6(c) and your continued compliance with all restrictive covenant
agreements to which you are bound, (i) you will be entitled to receive, as severance, your base salary in effect on the date of such termination for a period of twelve (12) months, (ii) you shall receive the 2012 Bonus referred to in
Section 2(b)(i) above, payable in accordance with the provisions of Section 2(b)(i)(A) and Section 2(b)(i)(B), (iii) with respect to any 2013 Bonus referred to in Section 2(b)(ii) above, you shall receive the greater of
(X) $150,000 or (Y) the portion of the 2013 Bonus achieved through the date of termination (to the extent applicable such amount to be paid from the Supplemental Bonus Trust), (iv) if your termination date is effective on or after
July 1 of any year subsequent to December 31, 2013 but before the payment of bonuses for any such year, you shall be entitled to the bonus that you would have received for such year at the time that bonuses are paid to other executive
officers of the Company, but in no event later than March 15 of the year following the year to which the bonus relates, (v) any of your option grants to purchase shares of WebMD Health Corp. made on or before July 23, 2011, which
remain outstanding at the time of such termination, to the extent unvested, shall remain outstanding and continue to vest as if you remained in the employ of the Company until the first anniversary 

  
 2 

 
of such date of termination, and (v) if you timely elect to continue your health insurance pursuant to COBRA, the Company shall reimburse you for the cost of your COBRA for a period of
twelve (12) months from the date of termination, or, if earlier, until such time as you are no longer eligible for COBRA or are otherwise eligible for comparable coverage with a subsequent employer, which reimbursement shall be made within
thirty (30) days after you provide evidence of your payment of such premiums, which evidence shall be provided no later than thirty (30) days after payment. The term “Change of Control of WebMD” shall have the meaning ascribed to
such term in the Equity Plan. In the event of termination of your employment for any other reason, you will receive compensation earned through the date of termination and your rights with respect to options and restricted stock will be as specified
in the applicable option or restricted stock agreements.” 
 Except as modified by the terms of this Amendment, the terms of the Offer Letter
(including, without limitation, Annex A thereto) remain in effect. Defined terms used herein shall have the meaning ascribed to such terms under the Offer Letter. Please acknowledge your agreement to the terms of this Amendment, by signing and
returning a copy to me. 
  

	
	Sincerely,
	
	/s/ Cavan Redmond
	
	Cavan Redmond
	Chief Executive Officer
	
	Agreed to and Accepted by:
	
	 /s/ Douglas W. Wamsley

	Douglas W. Wamsley

  
 3EX-10.64

 Exhibit 10.64 

CONFORMED COPY 
 WebMD Health
Corp. 
 111 Eighth Avenue 
 New
York, NY 10001 
 As of February 11, 2011 
 Michael Glick

 [address on file with Registrant] 
 Dear Mike: 

In recognition of the value of your services and in order to induce you to remain in its employ, WebMD Health Corp. (the
“Company”) has decided to enter into this agreement (the “Letter Agreement”) to confirm the following terms and conditions with respect to your continued employment with the Company: 

1. Term. The term of this Letter Agreement (the “Term”) begins on the date of this Letter Agreement and ends on
June 30, 2014 (unless sooner terminated in accordance with Section 6). 
 2. Title; Duties. Your title is Senior Vice
President – Legal of the Company. It is expected that you will continue (including following the occurrence of a Change of Control of the Company (as defined on Annex A)) to use your best and most diligent efforts to perform your duties and
promote the interests of the Company and its affiliates and will devote all of your business time and attention to your employment with the Company. You agree to perform your duties for the Company in accordance with the Company’s policies and
procedures, including, without limitation, its Code of Conduct. 
 3. Base Salary and Bonus. 

(a) Your current annual base salary is $200,000 (as it may be increased “Base Salary”) and will be paid in accordance with
the Company’s prevailing payroll practices. 
 (b) You will be eligible to receive an annual bonus, the amount of which will be
determined in the Company’s discretion or in accordance with a written bonus plan applicable to you (if any). 
 4. Benefits.
You will continue to be eligible to participate in the employee benefit programs of the Company in accordance with the terms of such programs, as they may be amended from time to time. 

5. Termination of Employment. 

(a) In the event that, during the Term, your employment is terminated by the Company without Cause (as defined on Annex A), the Company will
pay you compensation that you have earned through the date of termination of employment and any accrued but unpaid vacation, and subject to your execution of a release in a form satisfactory to the Company pursuant to Section 5(b) below and
your continued compliance with the restrictive covenants to which you are bound, the Company will have the following obligation to you, subject to Section 5(b) below: 

(i) The options to purchase the Company’s common stock under the two (2) separate option grants on December 10, 2008 and
June 28, 2010, respectively (collectively, the “Prior Stock Options”) will remain outstanding and each such grant will become vested on the next scheduled vesting date following the date of your termination of employment to the extent
that the applicable grant would have otherwise become vested on its next vesting date if you had remained in the employ of the Company through such vesting date (and any remaining unvested portion of such grant will then expire), and each such grant
to the extent vested, will remain outstanding for a period of three (3) months from such vesting date; and 

 (ii) On the date of your termination of employment, the shares of restricted stock of the Company
that were granted to you under three (3) separate grants of restricted stock on December 10, 2008, December 8, 2009 and June 28, 2010, respectively (collectively, the “Prior Restricted Shares”) will become vested
to the extent that each such grant would have otherwise have become vested on its next scheduled vesting date following termination of employment if your employment had not terminated (and you will forfeit the remaining unvested Prior Restricted
Shares covered by each such grant). 
 (b) In order to receive any of the benefits described in Sections 5(a)(i)-(ii) under the
Agreement (the “Severance Benefits”), you must (i) execute and deliver to the Company a release of claims in a form satisfactory to the Company within the time prescribed therein but in no event later than fifty (50) days
of the date of your termination of employment and (ii) not revoke such release pursuant to any revocations rights afforded by law. The Company shall provide to you the release no later than three (3) days following your termination of
employment. If you do not timely execute and deliver to the Company such release, or if you execute a release but revoke it, no Severance Benefits shall be paid. 

(c) For purpose of this Agreement, “termination of employment” shall mean a “separation of service” as defined in
Section 409A of the Internal Revenue Code of 1986, as amended, (the “Code”) and Treasury Regulations Section 1.409A-1(h) without regard to the optional alternative definitions available thereunder. 

(d) Notwithstanding anything to the contrary in this Letter Agreement, the exercisability of any stock option will not extend beyond the
expiration of the original term of such stock option. 
 (e) In the event of the termination of your employment for any reason other than
those specified in Section 5(a) above or 6 below, you will only be entitled to your compensation earned through the date of termination and any accrued, but unpaid vacation. 

6. Change in Control. 

In the event that following the occurrence of a Change of Control of the Company (as defined on Annex A), you are terminated by the Company
without Cause, the Company will pay you compensation that you have earned through the date of termination of employment and any accrued but unpaid vacation, and subject to your execution of a release in a form satisfactory to the Company pursuant to
Section 5(b) above and your continued compliance with the restrictive covenants to which you are bound, the Company will have the following obligation to you, subject to Section 5(b) above: 

(i) The Prior Stock Options will remain outstanding and each grant covered thereby will become vested on each of the scheduled vesting date(s)
of each such grant following the date of your termination of employment to the extent that the each such grant would have otherwise become vested on 

  
 2 

 
each such vesting date(s) if you had remained in the employ of the Company through each such vesting date(s) and until the Prior Stock Options are fully vested, and the Prior Stock Options, to
the extent vested, will remain outstanding for a period of one (1) year from the applicable vesting date(s) of the Prior Stock Options; and 

(ii) On the date of your termination of employment, all unvested Prior Restricted Shares will become vested to the extent that such Prior
Restricted Shares are unvested as of such termination date. 
 7. Section 409A. 

(a) Potential Six-Month Delay. Notwithstanding any other provisions of this Letter Agreement, any payment of the Severance Benefits
under this Letter Agreement that the Company reasonably determines is subject to Section 409A(a)(2)(B)(i) of the Code shall not be paid or payment commenced until the later of (i) six (6) months after the date of your termination of
employment (or, if earlier, your death) and (ii) the payment date or commencement date specified in this Letter Agreement for such payment(s). On the earliest date on which such payments can be commenced without violating the requirements of
Section 409A(a)(2)(B)(i) of the Code, you shall be paid, in a single cash lump sum, an amount equal to the aggregate amount of all payments delayed pursuant to the preceding sentence. 

(b) Savings Clause. It is intended that any amounts payable under this Letter Agreement shall either be exempt from Section 409A
of the Code (including Treasury regulations and other published guidance related thereto) or shall otherwise comply with such Section so as not to subject you to payment of any additional tax, penalty or interest imposed under Section 409A of
the Code. The provision of this Letter Agreement shall be construed and interpreted to avoid the imputation of any such additional tax, penalty or interest under Section 409A of the Code yet preserve (to the nearest extent reasonably possible)
the intended benefit payable to you. Notwithstanding the foregoing, the Company makes no representation or warranty and shall have no liability to you or to any other person if any of the provisions of the agreement are determined to constitute
deferred compensation subject to Section 409(A), but that do not satisfy an exemption from, or the conditions of, that section. 
 9.
Effect on Prior Agreements. 
 (a) You will continue to be bound by, and you hereby reaffirm your obligations under, your Key
Employee Agreement, Trade Secret & Proprietary Information Agreement or similar agreement (including one contained in an option agreement or restricted stock agreement). In the event of a material breach of such agreement, the
Company’s obligations under this Letter Agreement will cease (including, without limitation, any right you may otherwise have to additional vesting or extension of the term of the Prior Stock Options and additional vesting of Prior Restricted
Shares hereunder). 
 (b) This Letter Agreement supersedes any prior agreement affecting the terms of your employment with the Company
(including, without limitation, the Letter Agreement dated as of February 10, 2006, as amended as of November 24, 2008), other than the award agreements and restrictive covenant agreements referred to herein. 

10. Miscellaneous. 
 (a)
All payments to you will be subject to applicable tax withholding obligations. 

  
 3 

 (b) The terms of this Letter Agreement will be governed by the laws of the State of New York.

 (c) The headings contained in this Letter Agreement are for reference purposes only and do not affect the meaning or interpretation of
the Letter Agreement. 
 (d) Any provisions of this Letter Agreement, which by their terms are intended to survive the Term, shall survive
the expiration of the Term. 
 (e) This Letter Agreement shall be binding on and assignable to any successors and/or assigns of the Company,
without your consent. 
 (f) You acknowledge that your employment with the Company is for an unspecified duration that constitutes at-will
employment, and that either you or the Company can terminate this relationship at any time, with or without Cause and with or without notice, subject to the consequences set forth above. 

We look forward to continuing our working relationship. 

 

					
	Sincerely,
	
	WEBMD HEALTH CORP.
		
	By:		 /s/ Douglas W. Wamsley

			Name:		Douglas W. Wamsley
			Title:		Executive Vice President

  

			
	Agreed to:		 /s/ Michael B. Glick

			Michael Glick

			
		
	Date:		 February 11, 2011

  
 4 

 Annex A to Letter Agreement 

“Cause” means any of the following: 

(i) your willful failure to perform your duties following written notice from the Company detailing the specific acts and a thirty
(30) day period of time to remedy such failure; 
 (ii) any willful misconduct, violence or threat of violence that is injurious to the
Company in a material respect or any misconduct relating to your business affairs, at any time, which shall demonstrably reflect negatively upon the Company or otherwise impair or impede its operations or reputation in any material respect; 

(iii) your breach of a material Company policy, which breach is not remedied (if susceptible to remedy) following written notice by the
Company detailing the specific breach and a thirty (30) day period of time to remedy such breach; 
 (iv) any material breach by you of
this Agreement or the Trade Secret and Proprietary Information Agreement, which breach is not remedied (if susceptible to remedy) following written notice by the Company or its designee detailing the specific breach and a thirty (30) day period
of time to remedy such breach; or 
 (v) your conviction of a felony in respect of a dishonest or fraudulent act or other crime of moral
turpitude. 
 A “Change of Control” of the Company has the meaning specified in the WebMD Health Corp. Restated 2005
Long-Term Incentive Plan in effect as of the date specified at the top of this Letter Agreement.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}]]